Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
Meyer
Andreas
A
Department of Radiation Oncology, Medical School Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
John
Esther
E
Dörk
Thilo
T
Sohn
Christof
C
Karstens
Johann H
JH
Bremer
Michael
M
D000328:Adult; D000368:Aged; D064007:Ataxia Telangiectasia Mutated Proteins; D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D011836:Radiation Tolerance / Q000235:genetics*; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases